Xiao Yasi, Gao Zu-Hua, Deschenes Marc
Department of Internal Medicine, McGill University, Montreal, Quebec, Canada.
Department of Pathology, McGill University, Montreal, Quebec, Canada.
Can Liver J. 2021 Apr 29;4(2):104-109. doi: 10.3138/canlivj-2020-0024. eCollection 2021 Spring.
Giant cell hepatitis (GCH) is a rare entity in adults that is characterized by large multinucleated hepatocyte formation and parenchymal inflammation. We present a case of acute liver failure in a 33-year-old woman secondary to autoimmune hepatitis (AIH). A liver biopsy revealed submassive hepatocyte necrosis consistent with GCH. We conducted a literature review of 187 reported cases of post-infantile GCH in adults. AIH was the most commonly reported cause of GCH, but GCH was associated with a wide spectrum of etiologies, including infections, rheumatological diseases, hematological diseases, malignancies, and medications. The severity of disease can range from mild hepatitis to fulminant hepatic failure. The mortality rate among the cases in the literature was 18.82%. GCH is managed by treating the underlying cause, and ribavirin has been proposed as a treatment option for idiopathic GCH. A small number of patients progress to requiring orthotopic liver transplant, but recurrence is possible post-transplant.
巨细胞性肝炎(GCH)在成人中是一种罕见疾病,其特征为形成大量多核肝细胞以及实质炎症。我们报告一例33岁女性继发于自身免疫性肝炎(AIH)的急性肝衰竭病例。肝活检显示亚大块肝细胞坏死,符合GCH表现。我们对187例已报道的成人期婴儿期后GCH病例进行了文献综述。AIH是GCH最常见的报道病因,但GCH与多种病因相关,包括感染、风湿性疾病、血液系统疾病、恶性肿瘤及药物。疾病严重程度可从轻度肝炎到暴发性肝衰竭不等。文献中病例的死亡率为18.82%。GCH通过治疗潜在病因进行管理,利巴韦林已被提议作为特发性GCH的一种治疗选择。少数患者病情进展至需要原位肝移植,但移植后可能复发。